Lipanthyl Nt (Fenofibrate (Nanonised))

Fenofibrate activates the nuclear receptor PPARα, which regulates genes involved in fatty‑acid oxidation and lipoprotein metabolism. This activation increases the breakdown of fatty acids, reduces hepatic triglyceride production, and enhances clearance of triglyceride‑rich particles, resulting in lower plasma triglycerides and modest HDL‑cholesterol rises.

The appropriate dose of Lipanthyl Nt is determined by the prescribing healthcare professional based on the individual’s clinical condition, laboratory results, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for fenofibrate in pregnancy and lactation are limited, and the product is generally not recommended for use unless the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their physician.

To order Lipanthyl Nt, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

The primary alternative to fenofibrate is the statin class, which primarily lowers LDL‑cholesterol. Fenofibrate is more effective at reducing triglycerides and modestly raising HDL‑cholesterol, whereas statins have a stronger impact on LDL‑cholesterol. In some patients, a combination of a statin and a fibrate may be used, but careful monitoring for muscle toxicity is required.

Lipanthyl Nt should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and excessive heat. Keep the product out of reach of children and avoid exposure to direct sunlight.

Lipanthyl Nt is taken orally, usually with a meal to enhance absorption. The tablet should be swallowed whole with a full glass of water. Patients should not crush or chew the tablet unless specifically instructed by a healthcare professional.

The most serious adverse reactions include rhabdomyolysis (severe muscle breakdown), acute liver injury, and pancreatitis. Patients should promptly report unexplained muscle pain, weakness, dark urine, jaundice, or severe abdominal pain to their healthcare provider.

Lipanthyl Nt should be avoided in patients with severe hepatic impairment, active gallbladder disease, known hypersensitivity to fenofibrate or other fibrates, and in individuals for whom the risk outweighs the benefit, such as certain pregnant or nursing women. Contraindications are confirmed by the prescribing clinician.